Stocks · Health care · Pharmaceutical Preparations

Organon & Co.

OGN Clue Score37
United States Fiscal year ends December CIK 0001821825 Results filed 30 Apr 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Matthew M Walsh
5 Aug 2021
Chief Financial Officer
Exercised, kept
22,343
$28.63
$639.68K
Rachel A Stahler
5 Aug 2021
Chief Information Officer
Exercised, kept
12,890
$28.63
$369.04K
Deborah H Telman
5 Aug 2021
EVP GC & Corporate Secretary
Exercised, kept
6,445
$28.63
$184.52K

What was left out

Form 4 filings counted 282
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 256,219,868
History held since 4 Jun 2021